Skip to main content

Navigation group

Type at least 3 characters
377 articles

Articles

Original Research

Published on 18 Jul 2024

Expression of pro- and anti-inflammatory cytokines during anti-proprotein convertase subtilisin/kexin type 9 therapy in patients with statin-resistant familial hypercholesterolemia

in Cardiovascular Metabolism

  • Julieta Danira Morales-Portano
  • Rafael Trujillo-Cortés
  • Bricia Margarita Roa-Martínez
  • Rebeca Pérez-Cabeza de Vaca
  • Silvia García
  • Paul Mondragón-Terán
  • Juan A. Suárez-Cuenca
Expression of pro- and anti-inflammatory cytokines during anti-proprotein convertase subtilisin/kexin type 9 therapy in patients with statin-resistant familial hypercholesterolemia
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1417044
  • 193 views

Clinical Trial

Published on 21 Feb 2024

Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study

in Cardiovascular Metabolism

  • Lucas Lage Marinho
  • Fabiana Hanna Rached
  • Aleksandra Tiemi Morikawa
  • Thauany Martins Tavoni
  • Ana Paula Toniello Cardoso
  • Roberto Vitor Almeida Torres
  • Antonildes Nascimento Assuncao
  • Carlos Vicente Serrano
  • Cesar Higa Nomura
  • Raul Cavalcante Maranhão
Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1342832
  • 1,262 views